Skip to content

Advances in Motion provides health care professionals with information about the latest breakthroughs, research and clinical advances from Massachusetts General Hospital.

Featured In Cardiovascular

Evaluation of carotid artery disease procedures confirms Massachusetts General Hospital as a regional and national leader in benchmarks related to patient outcomes.

Featured In Radiology

Ultrasound-guided cryoablation offers a range of advantages over conventional approaches to treating breast cancer. In October 2023, Massachusetts General Hospital successfully introduced the technique into its clinical practice.

Featured In Neuroscience

Physician-investigators at Massachusetts General Hospital recently published findings that provide a critical step forward in understanding the mechanisms underlying a host of neurodegenerative diseases.

Featured In Digestive Health

At the American College of Gastroenterology 2023 Scientific Meeting, Mythili Pathipati, MD, presented findings from a real-world study where app-delivered cognitive behavioral therapy resulted in a significant reduction in symptom severity and perceived stress for patients with irritable bowel syndrome.

Featured In Orthopaedics

In this video from Orthopedics Today, sports medicine orthopedic surgeon Miho Tanaka, MD, PhD, describes how three- and four-dimensional imaging technology is advancing clinical understandings of knee conditions such as trochlear dysplasia and patellar instability.

The Latest Oncology Advances

Guoliang Qiao, MD, PhD, Motaz Qadan, MD, PhD, and colleagues demonstrated patients ≥75 years old with pancreatic ductal adenocarcinoma were associated with longer overall and recurrence-free survival if they underwent neoadjuvant chemotherapy instead of upfront surgical resection; postoperative complication rates were similar.

A retrospective study at Massachusetts General Hospital and two other centers found cancer patients who had an immune checkpoint inhibitor restarted after an episode of immune-related enterocolitis had significantly less risk of severe recurrent enterocolitis if they concurrently received infliximab or vedolizumab.

Contributing Physicians

Director of Precision Medicine, Center for Breast Cancer, Mass General Cancer Center, Founding Director, Molecular and Precision Medicine Metastatic Breast Cancer Clinic, Mass General Cancer Center, Assistant Professor in Medicine, Harvard Medical School

Aditya Bardia, MD, MPH

Director, Central Nervous System Metastasis Center, Mass General Cancer Center, Associate Professor of Medicine, Harvard Medical School

Priscilla K. Brastianos, MD

Advances Specialties


Annekathryn Goodman, MD, gynecologic oncologist and co-director of Women's Global Health at Massachusetts General Hospital, and colleagues have documented a need for Ukraine to expand awareness of and access to cervical cancer screening and human papillomavirus vaccination programs.

Pulmonary and Critical Care

Ramnik J. Xavier, MD, PhD, Haroon Kalam, PhD, and colleagues have identified the host transcriptome involved in various phenotypic states of Mycobacterium tuberculosis (Mtb) infection of macrophages and have pinpointed MMGT1–GPR156 signaling as a regulator of the lipid droplet formation that helps latent Mtb survive.

Rheumatology, Allergy and Immunology

In a recent Medical Grand Rounds presentation, Allen C. Steere, MD, shared his 50-year journey investigating Lyme arthritis, beginning in the 1970s with his identification and description of the clinical syndrome and leading to many pivotal discoveries throughout his decades of work.

Education & Training Opportunities

December 5-9, 2023

At the 46th annual San Antonio Breast Cancer Symposium (SABCS), leading faculty from the Mass General Cancer Center will join over 10,000 international clinicians and scientists to contribute their latest advancements in breast cancer research.

December 9-12, 2023

The Mass General Cancer Center will present their latest research at the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, CA. In its 65th year, the ASH Annual Meeting & Exposition offers educational meetings and workshops for hematology professionals from around the world.